Cargando…
Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China
BACKGROUND: COPD is the fourth leading cause of death worldwide, with particularly high rates in the People’s Republic of China, even among never smokers. Large population-based cohort studies should allow for reliable assessment of the determinants of diseases, which is dependent on the quality of...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780206/ https://www.ncbi.nlm.nih.gov/pubmed/27042034 http://dx.doi.org/10.2147/COPD.S100736 |
_version_ | 1782419740081258496 |
---|---|
author | Kurmi, Om P Vaucher, Julien Xiao, Dan Holmes, Michael V Guo, Yu Davis, Kourtney J Wang, Chen Qin, Haiyan Turnbull, Iain Peng, Peng Bian, Zheng Clarke, Robert Li, Liming Chen, Yiping Chen, Zhengming |
author_facet | Kurmi, Om P Vaucher, Julien Xiao, Dan Holmes, Michael V Guo, Yu Davis, Kourtney J Wang, Chen Qin, Haiyan Turnbull, Iain Peng, Peng Bian, Zheng Clarke, Robert Li, Liming Chen, Yiping Chen, Zhengming |
author_sort | Kurmi, Om P |
collection | PubMed |
description | BACKGROUND: COPD is the fourth leading cause of death worldwide, with particularly high rates in the People’s Republic of China, even among never smokers. Large population-based cohort studies should allow for reliable assessment of the determinants of diseases, which is dependent on the quality of disease diagnoses. We assessed the validity of COPD diagnoses collected through electronic health records in the People’s Republic of China. METHODS: The CKB study recruited 0.5 million adults aged 30–79 years from ten diverse regions in the People’s Republic of China during the period 2004–2008. During 7 years of follow-up, 11,800 COPD cases were identified by linkage with mortality registries and the national health insurance system. We randomly selected ~10% of the reported COPD cases and then undertook an independent adjudication of retrieved hospital medical records in 1,069 cases. RESULTS: Overall, these 1,069 cases were accrued over a 9-year period (2004–2013) involving 153 hospitals across ten regions. A diagnosis of COPD was confirmed in 911 (85%) cases, corresponding to a positive predictive value of 85% (95% confidence interval [CI]: 83%–87%), even though spirometry testing was not widely used (14%) in routine hospital care. The positive predictive value for COPD did not vary significantly by hospital ranking or calendar period, but was higher in men than women (89% vs 79%), at age ≥70 years than in younger people (88%, 95% CI: 85%–91%), and when the cases were reported from both death registry and health insurance systems (97%, 95% CI: 94%–100%). Among the remaining cases, 87 (8.1%) had other respiratory diseases (chiefly pneumonia and asthma; n=85) and 71 (6.6%) cases showed no evidence of any respiratory disease on their clinical records. CONCLUSION: In the People’s Republic of China, COPD diagnoses obtained from electronic health records are of good quality and suitable for large population-based studies and do not warrant systematic adjudication of all the reported cases. |
format | Online Article Text |
id | pubmed-4780206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-47802062016-04-01 Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China Kurmi, Om P Vaucher, Julien Xiao, Dan Holmes, Michael V Guo, Yu Davis, Kourtney J Wang, Chen Qin, Haiyan Turnbull, Iain Peng, Peng Bian, Zheng Clarke, Robert Li, Liming Chen, Yiping Chen, Zhengming Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: COPD is the fourth leading cause of death worldwide, with particularly high rates in the People’s Republic of China, even among never smokers. Large population-based cohort studies should allow for reliable assessment of the determinants of diseases, which is dependent on the quality of disease diagnoses. We assessed the validity of COPD diagnoses collected through electronic health records in the People’s Republic of China. METHODS: The CKB study recruited 0.5 million adults aged 30–79 years from ten diverse regions in the People’s Republic of China during the period 2004–2008. During 7 years of follow-up, 11,800 COPD cases were identified by linkage with mortality registries and the national health insurance system. We randomly selected ~10% of the reported COPD cases and then undertook an independent adjudication of retrieved hospital medical records in 1,069 cases. RESULTS: Overall, these 1,069 cases were accrued over a 9-year period (2004–2013) involving 153 hospitals across ten regions. A diagnosis of COPD was confirmed in 911 (85%) cases, corresponding to a positive predictive value of 85% (95% confidence interval [CI]: 83%–87%), even though spirometry testing was not widely used (14%) in routine hospital care. The positive predictive value for COPD did not vary significantly by hospital ranking or calendar period, but was higher in men than women (89% vs 79%), at age ≥70 years than in younger people (88%, 95% CI: 85%–91%), and when the cases were reported from both death registry and health insurance systems (97%, 95% CI: 94%–100%). Among the remaining cases, 87 (8.1%) had other respiratory diseases (chiefly pneumonia and asthma; n=85) and 71 (6.6%) cases showed no evidence of any respiratory disease on their clinical records. CONCLUSION: In the People’s Republic of China, COPD diagnoses obtained from electronic health records are of good quality and suitable for large population-based studies and do not warrant systematic adjudication of all the reported cases. Dove Medical Press 2016-03-01 /pmc/articles/PMC4780206/ /pubmed/27042034 http://dx.doi.org/10.2147/COPD.S100736 Text en © 2016 Kurmi et al. This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Original Research Kurmi, Om P Vaucher, Julien Xiao, Dan Holmes, Michael V Guo, Yu Davis, Kourtney J Wang, Chen Qin, Haiyan Turnbull, Iain Peng, Peng Bian, Zheng Clarke, Robert Li, Liming Chen, Yiping Chen, Zhengming Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China |
title | Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China |
title_full | Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China |
title_fullStr | Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China |
title_full_unstemmed | Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China |
title_short | Validity of COPD diagnoses reported through nationwide health insurance systems in the People’s Republic of China |
title_sort | validity of copd diagnoses reported through nationwide health insurance systems in the people’s republic of china |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780206/ https://www.ncbi.nlm.nih.gov/pubmed/27042034 http://dx.doi.org/10.2147/COPD.S100736 |
work_keys_str_mv | AT kurmiomp validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT vaucherjulien validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT xiaodan validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT holmesmichaelv validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT guoyu validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT daviskourtneyj validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT wangchen validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT qinhaiyan validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT turnbulliain validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT pengpeng validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT bianzheng validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT clarkerobert validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT liliming validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT chenyiping validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina AT chenzhengming validityofcopddiagnosesreportedthroughnationwidehealthinsurancesystemsinthepeoplesrepublicofchina |